Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease

References

• PostmaDSBushAvan den BergeMRisk factors and early origins of chronic obstructive pulmonary diseaseLancet2015385997189990925123778
   PubMed Web of Science ®Google Scholar
• SmithMCWrobelJPEpidemiology and clinical impact of major comorbidities in patients with COPDInt J Chron Obstruct Pulmon Dis2014987188825210449
   PubMed Web of Science ®Google Scholar
• LiuYCroftJBAndersonLAWheatonAGPresley-CantrellLRFordESThe association of chronic obstructive pulmonary disease, disability, engagement in social activities, and mortality among US adults aged 70 years or older, 1994–2006Int J Chron Obstruct Pulmon Dis20149758324477269
   PubMed Web of Science ®Google Scholar
• DrummondMBHanselNNConnettJEScanlonPDTashkinDPWiseRASpirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012185121301130622561963
   PubMed Web of Science ®Google Scholar
• TerzanoCContiVDi StefanoFComorbidity, hospitalization, and mortality in COPD: results from a longitudinal studyLung2010188432132920066539
   PubMed Web of Science ®Google Scholar
• ZhangLLGongJLiuCTVitamin D with asthma and COPD: not a false hope? A systematic review and meta-analysisGenet Mol Res20141337607761624615096
   PubMed Web of Science ®Google Scholar
• AutierPBoniolMPizotCMulliePVitamin D status and ill health: a systematic reviewLancet Diabetes Endocrinol201421768924622671
   PubMed Web of Science ®Google Scholar
• AfzalSLangePBojesenSEFreibergJJNordestgaardBGPlasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary diseaseThorax2014691243123908128
   PubMed Web of Science ®Google Scholar
• PuhanMASiebelingLZollerMMuggensturmPter RietGSimple functional performance tests and mortality in COPDEur Respir J201342495696323520321
   PubMed Web of Science ®Google Scholar
• MobergMVestboJMartinezGValidation of the i-BODE index as a predictor of hospitalization and mortality in patients with COPD participating in pulmonary rehabilitationCOPD201411438138724111845
   PubMedGoogle Scholar
• PereraPNArmstrongEPSherrillDLSkrepnekGHAcute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortalityCOPD20129213114122409371
   PubMedGoogle Scholar
• RyynanenOPSoiniEJLindqvistAKilpelainenMLaitinenTBayesian predictors of very poor health related quality of life and mortality in patients with COPDBMC Med Inform Decis Mak2013133423496851
   PubMed Web of Science ®Google Scholar
• PapaioannouAIBartziokasKLoukidesSCardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?Eur Respir J Epub2015416
   Web of Science ®Google Scholar
• RizaALPearsonFUgarte-GilCClinical management of concurrent diabetes and tuberculosis and the implications for patient servicesLancet Diabetes Endocrinol20142974075325194887
   PubMed Web of Science ®Google Scholar
• RockKLKataokaHLaiJJUric acid as a danger signal in gout and its comorbiditiesNat Rev Rheumatol201391132322945591
   PubMed Web of Science ®Google Scholar
• Alvarez-LarioBMacarron-VicenteJIs there anything good in uric acid?QJM2011104121015102421908382
   PubMed Web of Science ®Google Scholar
• BardinTRichettePDefinition of hyperuricemia and gouty conditionsCurr Opin Rheumatol201426218619124419750
   PubMed Web of Science ®Google Scholar
• Ghaemi-OskouieFShiYThe role of uric acid as an endogenous danger signal in immunity and inflammationCurr Rheumatol Rep201113216016621234729
   PubMed Web of Science ®Google Scholar
• KimSYGuevaraJPKimKMChoiHKHeitjanDFAlbertDAHyperuricemia and coronary heart disease: a systematic review and meta-analysisArthritis Care Res (Hoboken)201062217018020191515
   PubMed Web of Science ®Google Scholar
• KimSYGuevaraJPKimKMChoiHKHeitjanDFAlbertDAHyperuricemia and risk of stroke: a systematic review and meta-analysisArthritis Rheum200961788589219565556
   PubMed Web of Science ®Google Scholar
• HorsfallLJNazarethIPetersenISerum uric acid and the risk of respiratory disease: a population-based cohort studyThorax201469111021102624904021
   PubMed Web of Science ®Google Scholar
• BraghiroliASaccoCErbettaMRugaVDonnerCFOvernight urinary uric acid: creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressureAm Rev Respir Dis199314811731788317794
   PubMed Web of Science ®Google Scholar
• Garcia-PachonEPadilla-NavasIShumCSerum uric acid to creatinine ratio in patients with chronic obstructive pulmonary diseaseLung20071851212417294336
   PubMed Web of Science ®Google Scholar
• FabbriLMHurdSSGlobal strategy for the diagnosis, management and prevention of COPD: 2003 updateEur Respir J20032211212882441
   PubMed Web of Science ®Google Scholar
• (GOLD) GIfCOLDGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2013Global Initiative for Chronic Obstructive Lung Disease (GOLD)2013 Available from: www.goldcopd.com
   Google Scholar
• SuissaSDell’AnielloSErnstPLong-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax2012671195796322684094
   PubMed Web of Science ®Google Scholar
• StällbergBJansonCJohanssonGManagement, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS)Prim Care Respir J2014231384524346825
   PubMedGoogle Scholar
• WilliamsMCMurchisonJTEdwardsLDEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsCoronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortalityThorax201469871872324473329
   PubMed Web of Science ®Google Scholar
• BollandMJGreyAGambleGDReidIRThe effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysisLancet Diabetes Endocrinol20142430732024703049
   PubMed Web of Science ®Google Scholar
• OdoneAHoubenRMWhiteRGLonnrothKThe effect of diabetes and undernutrition trends on reaching 2,035 global tuberculosis targetsLancet Diabetes Endocrinol20142975476425194888
   PubMed Web of Science ®Google Scholar
• NicksMEO’BrienMMBowlerRPPlasma antioxidants are associated with impaired lung function and COPD exacerbations in smokersCOPD20118426426921627570
   PubMedGoogle Scholar
• DomejWOettlKRennerWOxidative stress and free radicals in COPD – implications and relevance for treatmentInt J Chron Obstruct Pulmon Dis201499120791224
   Web of Science ®Google Scholar
• TseHNTsengCZUpdate on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2014982583625125976
   PubMed Web of Science ®Google Scholar
• BillietLDoatySKatzJDVelasquezMTReview of hyperuricemia as new marker for metabolic syndromeISRN Rheumatol2014201485295424693449
   PubMedGoogle Scholar
• BartziokasKPapaioannouAILoukidesSSerum uric acid as a predictor of mortality and future exacerbations of COPDEur Respir J2014431435323645404
   PubMed Web of Science ®Google Scholar
• SatoNKurashimaKUbukataMPrognostic significance of serum uric acid in patients with chronic obstructive pulmonary disease receiving home oxygen therapyNihon Kokyuki Gakkai Zasshi2003412748012722324
   PubMedGoogle Scholar
• PlywaczewskiRBednarekMJonczakLGoreckaDSliwiniskiPHiperurykemia u kobiet z obturacyjny bezdech senny [Hyperuricaemia in males with obstructive sleep apnoea (osa)]Pneumonol Alergol Pol2005733254259 Polish16989162
   PubMedGoogle Scholar